What's new
Last updated on Thursday, 13 February 2025 at 08:35pm
We regularly update the dashboard with new data and features. Here we'll show a timeline of changes that have happened outside of the weekly data refresh.
- Entry category: UpdateEntry title: Dashboard update frequency reduced for the festive period
On Wednesday 24 December 2025 at 2pm some of the metrics will be updated on the UKHSA data dashboard, these will include:
- COVID-19 case numbers and positivity metrics
- Influenza positivity, healthcare and FluSurvey metrics
- Positivity metrics for RSV and other respiratory viruses
- Syndromic surveillance metrics for respiratory conditions and winter seasonal environmental conditions
Data on the dashboard will not be updated on the week of 29 December 2025.
Regular weekly dashboard updates will resume from Thursday 8 January 2026.
- Entry category: New metricEntry title: Impact of cold metrics added to the dashboard
The dashboard now shows data on the impact of cold in England, from the Emergency Department Syndromic Surveillance System. Weekly updates will continue through to the end of March 2026.
These data can be found in the seasonal environmental conditions section.
- Entry category: New metricEntry title: FluSurvey data for England added to the UKHSA data dashboard
More data has been added to the dashboard under the Influenza topic within the respiratory viruses theme. This includes the weekly rate of reported influenza-like illness and the weekly number of participants in the FluSurvey. FluSurvey (https://flusurvey.net/) is an online surveillance tool that monitors self-reported respiratory symptoms, social contact patterns and use of health services in the UK.
Monitoring the number of people reporting influenza-like illness helps track flu and other respiratory virus activity in the community.
- Entry category: New metricEntry title: Hepatitis B (HBV) in England data added to dashboard
Data showing HBV in England is now available as part of the blood-borne viruses theme.
This includes the number of people estimated to be living with HBV, maternal screening coverage and HBV deaths, along with other metrics.
Multiple sources of data are used to track progress over time. More information can be found in the metrics documentation.
The hepatitis B virus affects the liver. It is a major public health threat in the UK.
- Entry category: Change to metricEntry title: Mpox clade Ib and mpox clade IIb reporting now monthly
From Thursday 16 October the frequency of updates to mpox clade Ib and mpox clade IIb data will reduce from weekly to monthly to match the epidemiological overview published on GOV.UK. This change reflects the current situation where case numbers remain low and stable.
The national response to the mpox outbreak is now being scaled back as there is no longer a need for an active outbreak response. Routine public health surveillance will continue to monitor any new cases and provide updates when needed. If the situation changes the UKHSA will review the reporting frequency and provide updates as required.
- Entry category: New metricEntry title: Adding childhood vaccination coverage to the UKHSA data dashboard
Data presented on the dashboard are Accredited Official Statistics and supplement the annual report for the cover of vaccinations evaluated rapidly (COVER) programme.
Annual childhood vaccination coverage statistics represent data collected from local authorities in England, Regions in England and countries of the UK.
The data reflects vaccination coverage by 12 months, 24 months and 5 years of age, not the age at the time of vaccination.
Adding these statistics to the dashboard has provided opportunities to introduce new features including interactive maps, charts and data filters.
Insights from surveys, interviews and usability testing have shaped each stage of development. User feedback has been central to ensuring user needs are met by sharing data in a way that is clear, easy to understand and meets statistical standards.
- Entry category: UpdateEntry title: Addition of measles into the Outbreaks section
Data for measles can now be found under both the Outbreaks and Vaccine-preventable diseases themes on the dashboard.
Measles activity in England has increased steadily since April 2025 and UKHSA is overseeing the public health risk assessment and response.
- Entry category: New metricEntry title: Antimicrobial resistance in E. coli bacteriuria added to the dashboard
More data has been added to the dashboard under the Antimicrobial Resistance (AMR) theme. This includes data for antimicrobial resistance to E. coli bacteriuria (bacteria in urine samples).
Timely monitoring of susceptibility test results for Escherichia coli (E. coli) supports the government’s 5-year action plan on confronting antimicrobial resistance.
Sharing this data will help to identify emerging trends in AMR. Antimicrobials presented in this metric have been selected due to their clinical importance when treating E. coli infections in urine specimens.
- Entry category: New metricEntry title: Heat exposure, sunburn and sunstroke metrics added to the dashboard
The dashboard now shows several indicators of syndromic surveillance data on cases of heat exposure, sunburn and sunstroke in England.
There is a new section called 'seasonal environmental conditions'.
Data showing the daily number of emergency department attendances, the daily GP in-hours consultation rate for and NHS 111 triaged calls are now available in the Syndromic Surveillance section of the dashboard.
- Entry category: Change to metricEntry title: Antimicrobial resistance (AMR) updated
Data showing antimicrobial resistance in E. coli bacteraemia has been expanded. It is now possible to see resistance to several further antimicrobials.
The time series of the data has also been extended and now goes back 5 years, to 2020.
Data is available for E.coli bacteraemia tested for resistance to the following:
- amikacin
- carbapenems
- third-generation cephalosporins
Timely monitoring of susceptibility test results for Escherichia coli (E. coli) supports the government’s 5-year action plan on confronting antimicrobial resistance.